Jerome Jack R, Wilson Kirsty L, Fialho Joshuah, Goodchild Georgia, Prakash Monica D, McLeod Charlie, Richmond Peter C, Apostolopoulos Vasso, Flanagan Katie L, Plebanski Magdalena
School of Health and Biomedical Science, Royal Melbourne Institute of Technology University, Melbourne, VIC, Australia.
Accelerator for Translational Research in Clinical Trials (ATRACT) Centre, School of Health and Biomedical Sciences, Royal Melbourne Institute of Technology University, Melbourne, VIC, Australia.
Front Immunol. 2025 Apr 15;16:1547220. doi: 10.3389/fimmu.2025.1547220. eCollection 2025.
This study presents an optimised cultured ELISpot protocol for detecting central memory T-cell interferon gamma (IFNγ) responses against SARS-CoV-2 peptides following an initial priming with either peptides, or whole spike protein.
Key variations optimised include the culture length, timing of exogenous survival signals (IL-2), and endpoint analysis modality and cell density to enhance assay sensitivity without compromising specificity for central memory T-cell IFNγ recall responses to cognate antigen.
We noted a culture duration of 10 days, combined with a delayed IL-2 administration on day 5 to enhance assay sensitivity while maintaining response specificity towards cognate antigen when compared with shorter culture periods or earlier exogenous survival signal provision. With regards to lower-frequency T-cell interactions, as we observed with our donor SARS-CoV-2 epitope responses, our findings suggest Fluorospot to be preferable to the chromogenic ELISpot modality, and an immediate cell washing after culture collection to better facilitate cognate antigen responses. Fluorospot enabled a higher cell density while minimising the generation of visual artefacts, meanwhile immediate cell washing was critical for improving endpoint assay sensitivity. CCR7+ cell depletion was used to demonstrate our optimised protocol to selectively demonstrate central memory T-cell responses. Lastly, we provide evidence for the capacity of our assay to delineate individual responding peptides following peptide pool priming, and to explore cross-reactivity between viral variant peptides.
This work advances the methodology for investigating T-cell immunity, particularly in the context of SARS-CoV-2, and emphasises the balance between enhancing specific cognate central memory responses while limiting non-specific activation.
本研究提出了一种优化的培养ELISpot方案,用于检测在用肽或全长刺突蛋白进行初次致敏后,针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)肽的中枢记忆T细胞干扰素γ(IFNγ)反应。
优化的关键变量包括培养时长、外源性存活信号(白细胞介素-2,IL-2)的添加时间、终点分析方式和细胞密度,以提高检测灵敏度,同时不影响中枢记忆T细胞对同源抗原的IFNγ回忆反应的特异性。
我们发现培养持续10天,结合在第5天延迟给予IL-2,与较短的培养期或更早提供外源性存活信号相比,可提高检测灵敏度,同时保持对同源抗原的反应特异性。对于低频T细胞相互作用,正如我们在供体SARS-CoV-2表位反应中观察到的那样,我们的研究结果表明荧光斑点法比显色ELISpot法更可取,并且在培养物收集后立即进行细胞洗涤,以更好地促进同源抗原反应。荧光斑点法能够实现更高的细胞密度,同时最大限度地减少视觉假象的产生,与此同时,立即进行细胞洗涤对于提高终点检测灵敏度至关重要。使用CCR7+细胞耗竭来证明我们的优化方案能够选择性地显示中枢记忆T细胞反应。最后,我们提供证据表明我们的检测方法能够在肽池致敏后描绘出个体反应肽,并探索病毒变异肽之间的交叉反应性。
这项工作改进了研究T细胞免疫的方法,特别是在SARS-CoV-2的背景下,并强调了在增强特异性同源中枢记忆反应的同时限制非特异性激活之间的平衡。